Can You Switch From Wegovy to Mounjaro Safely?
A clear, medically guided approach to switching weight loss injections with confidence
If you’re currently using Wegovy — or have used it in the past — it’s natural to wonder whether switching to Mounjaro is possible, and more importantly, whether it can be done safely.
This article explains when switching may be considered, how the process usually works in the UK, what the evidence shows, what to expect week by week, and what it costs — all under medical guidance.
The Short Answer
Yes — many patients can switch from Wegovy to Mounjaro safely, provided it’s done with the support of a qualified prescriber. The key is that switching should never be rushed or self-directed. A structured, medically guided transition helps ensure comfort, safety, and the best chance of success.
- You restart low: most people begin Mounjaro at 2.5mg regardless of their previous Wegovy dose
- Timing matters: a prescriber plans the gap between your last Wegovy dose and first Mounjaro dose
- Evidence: in the head-to-head SURMOUNT-5 trial, tirzepatide averaged 20.2% vs 13.7% for semaglutide
- Cost at Slinic: Mounjaro from £139/month; Wegovy from £99.99/month, both all-inclusive
What’s on this page
- Why Some People Consider Switching
- How Each Medication Works
- How Wegovy and Mounjaro Differ
- Wegovy vs Mounjaro at a Glance
- Why Weight Loss Can Plateau
- Is Switching Right for You?
- What the Evidence Says
- Step-by-Step: How a Switch Works
- Do You Need a Break Between Wegovy and Mounjaro?
- What Dose Would You Start On?
- Injecting Mounjaro: Practical Differences
- What to Expect Week by Week
- What Might Feel Different After Switching?
- Managing Side Effects During the Switch
- Common Mistakes to Avoid When Switching
- After the Switch: Follow-Up and Monitoring
- Wegovy and Mounjaro Pricing at Slinic
- Cost Considerations When Switching
- Preparing for Your Consultation
- Why Medical Guidance Is Essential
- Frequently Asked Questions
Why Some People Consider Switching
There are a number of reasons someone might explore switching treatments, including:
- Wanting a different appetite response
- Feeling weight loss has slowed or plateaued
- Experiencing side effects that are difficult to manage
- Looking for an option that better fits long-term goals
None of these reasons automatically mean one treatment is “better” — they simply reflect that weight loss journeys are individual. For a detailed comparison of both medications, see our guide on swapping between Mounjaro and Wegovy.
How Each Medication Works
Both Wegovy and Mounjaro are once-weekly injections that mimic gut hormones the body releases after eating. They reduce appetite, slow how quickly the stomach empties, and increase feelings of fullness — the effect many people describe as quieter “food noise.” The difference lies in how many hormone pathways each one acts on.
- Wegovy (semaglutide) acts on a single pathway, GLP-1. Semaglutide has a long half-life of around a week, which is part of why a planned gap matters when switching.
- Mounjaro (tirzepatide) is a dual agonist, acting on both GLP-1 and a second hormone, GIP. This dual action is thought to influence appetite and how the body handles energy in a slightly broader way.
Because they engage these pathways differently, two people can respond to the same medicine in different ways — and the same person can respond differently to each medicine. That is exactly why the decision to switch is an individual, clinically guided one rather than a one-size-fits-all rule.
How Wegovy and Mounjaro Differ
While both medications are weekly injections used to support weight loss, they work slightly differently in the body.
- Wegovy contains semaglutide, which targets one appetite-regulating hormone (GLP-1).
- Mounjaro contains tirzepatide, which works on two pathways (GLP-1 and GIP), influencing appetite and fullness in a broader way.
Because of these differences, people can experience each medication differently — which is why a personalised approach matters.
Understanding the dual-action mechanism
Mounjaro’s dual-action approach (targeting both GLP-1 and GIP receptors) may influence appetite and how the body uses energy differently compared to Wegovy’s single-receptor approach. This doesn’t make one “better” — it means responses can vary from person to person. In the head-to-head SURMOUNT-5 trial (NEJM 2025), tirzepatide achieved 20.2% mean weight loss vs 13.7% for semaglutide over 72 weeks, but individual responses still vary significantly.
Wegovy vs Mounjaro at a Glance
A side-by-side summary can make the practical differences clearer. Trial figures are population averages over roughly 72 weeks alongside diet and activity changes, not guarantees for any individual.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Hormone pathways | GLP-1 (single) | GLP-1 + GIP (dual) |
| Manufacturer | Novo Nordisk | Eli Lilly |
| How it’s taken | Once-weekly injection | Once-weekly injection |
| Maintenance / maximum dose | 2.4mg | 15mg |
| Average trial weight loss | ~13.7% (SURMOUNT-5); ~15% (STEP-1) | ~20.2% (SURMOUNT-5); up to ~22.5% (SURMOUNT-1) |
| Slinic monthly price range | £99.99 – £209.99 | £139 – £285 |
The headline difference is the second hormone pathway and the greater average weight loss seen with tirzepatide — but tolerability, suitability, and personal response all matter just as much as the averages.
Why Weight Loss Can Plateau
One of the most common reasons people ask about switching is that their weight loss on Wegovy has slowed or stalled. It’s worth understanding why this happens, because a plateau doesn’t automatically mean a medicine has stopped working or that switching is the only answer.
As you lose weight, your body needs fewer calories to function, so the same habits produce slower loss over time — this is normal physiology, not failure. Plateaus often appear once someone has been on a maintenance dose for a while, commonly around the twelve-to-fifteen-month mark. At that point there are usually a few options to discuss with a prescriber: reviewing diet and activity, confirming the dose is optimised, or considering whether a different medicine such as Mounjaro might suit you better.
It’s also worth remembering that these medicines work best as long-term treatment. Trial evidence (STEP-4) showed that stopping semaglutide led to much of the lost weight returning, which is why the conversation is usually about adjusting treatment rather than stopping it. For realistic timelines, see our guide on how long Mounjaro takes to work and on Mounjaro results week by week.
Is Switching Right for You?
Switching suits some people well and is not appropriate for others. A prescriber weighs up your reasons for switching against your medical history before agreeing a plan.
Switching may be considered if…
- Your weight loss on Wegovy has slowed and you have reached, or are close to, the maintenance dose
- You have tolerated GLP-1 treatment reasonably well overall
- You and your prescriber feel a different appetite response may help you progress
- You are committed to ongoing treatment alongside diet and activity changes
Extra caution, or not suitable, if…
- You are pregnant, trying to conceive, or breastfeeding
- You have a personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2 (MEN2)
- You have had pancreatitis or significant gallbladder problems
- You have severe gastrointestinal disease, or another condition your prescriber considers relevant
This is a clinical decision
The lists above are general guidance, not a self-assessment. Only a qualified prescriber, with your full medical history, can confirm whether switching is appropriate and safe for you.
What the Evidence Says
Clinical trials give a useful picture of average results, even though your own response may differ. The most relevant figures are summarised below.
| Trial | Medication | Mean weight loss | Duration |
|---|---|---|---|
| SURMOUNT-5 (head-to-head) | Tirzepatide (Mounjaro) | 20.2% | 72 weeks |
| SURMOUNT-5 (head-to-head) | Semaglutide (Wegovy) | 13.7% | 72 weeks |
| SURMOUNT-1 | Tirzepatide 15mg | ~22.5% | 72 weeks |
| STEP-1 | Semaglutide 2.4mg | ~15% | 68 weeks |
On average, tirzepatide produced greater weight loss than semaglutide, and SURMOUNT-5 is the only large trial to compare the two directly. The important caveat is that these are population averages: a person who responded modestly to Wegovy will not necessarily mirror the trial average on Mounjaro, and vice versa. The figures help set realistic expectations rather than guarantee a result.
Step-by-Step: How a Switch Works
A safe transition is a planned sequence rather than a single decision. While the exact details are tailored to you, the overall shape usually looks like this.
1Clinical review
A prescriber reviews your current Wegovy dose, how you have tolerated treatment, your weight loss so far, your medical history, and your reasons for switching.
2Planning the timing
If switching is appropriate, the prescriber plans a safe gap between your final Wegovy injection and your first Mounjaro injection, taking your current dose and tolerance into account.
3Finishing Wegovy
You complete your current Wegovy schedule as advised, without adding or doubling up doses.
4Starting Mounjaro at 2.5mg
You begin Mounjaro at the 2.5mg starter dose — even if you were on a higher Wegovy dose — so your body can adjust to the new mechanism.
5Gradual titration and review
Your dose is increased gradually based on how you respond, with pharmacist support at each stage. If side effects appear, your prescriber may hold a dose for longer before increasing.
Thinking About Starting Mounjaro?
The Slinic online consultation takes around three minutes. A pharmacist reviews your information within 24 hours — and pricing is transparent from the first dose.
Start Your Confidential ConsultationDo You Need a Break Between Wegovy and Mounjaro?
In many cases, a short gap or carefully timed transition is recommended — but this depends on:
- Your current Wegovy dose
- How well you’ve tolerated treatment
- Any side effects you’ve experienced
- Your overall health profile
A prescriber will decide the safest timing, rather than switching immediately without review.
Important safety note
Never attempt to switch between weight loss injections without medical guidance. Both medications have long half-lives and overlapping them could increase side effect risks. Your prescriber will determine the appropriate gap for your specific situation.
What Dose Would You Start On?
Even if you’ve previously been on a higher dose of Wegovy, most people start Mounjaro on the lowest dose (2.5mg).
This is because:
- 2.5mg is a starter dose, not a weight-loss dose
- It allows your body to adjust to a new medication
- It helps reduce the risk of side effects
Dose increases are then made gradually, based on how you respond. For a full breakdown of how dosing progresses, read our Mounjaro dosing schedule guide.
Why starting low matters
Even though you’ve been on a GLP-1 medication before, Mounjaro works on an additional pathway (GIP). Starting at 2.5mg allows your body to adjust to this new mechanism safely. Most patients see meaningful appetite changes and weight loss as doses increase — learn more in our guide on how long Mounjaro takes to work.
Injecting Mounjaro: Practical Differences
From a day-to-day point of view, switching is reassuringly familiar: like Wegovy, Mounjaro is a once-weekly injection you give yourself just under the skin. A few practical points help the transition go smoothly.
- Same weekly rhythm. You pick one day a week and keep to it, much as you did with Wegovy.
- Rotate your injection site. The abdomen, thigh, and upper arm are all suitable — varying the spot each week helps reduce injection-site reactions.
- Let it reach room temperature. Injecting straight from the fridge can sting more, so taking it out a little beforehand can help.
- Store it correctly. Follow the storage advice provided with your pen. Our guide to storing Mounjaro covers this in detail.
Your onboarding will include guidance on technique, so you don’t need to work this out alone. If anything feels unclear, your pharmacist can talk it through.
What to Expect Week by Week
Everyone is different, but a typical early experience after switching follows a recognisable shape as the dose builds.
- Weeks 1-4 (2.5mg): the starter phase. The main aim is letting your body adjust to tirzepatide; appetite suppression may feel milder than your previous Wegovy maintenance dose, and any mild side effects most often appear here.
- Week 5 onwards (5mg and up): if you are tolerating treatment, the dose is increased step by step. Appetite effects and weight loss typically build as the dose rises.
- Ongoing: your prescriber settles you at the lowest dose that gives a good response, and reviews progress over time.
If progress feels slow in the first few weeks, that is usually expected at the starter dose rather than a sign the medicine isn’t working. Our guide on how long Mounjaro takes to work sets out realistic timelines in more detail.
What Might Feel Different After Switching?
Some people notice:
- Appetite changes that feel slightly different
- A renewed sense of fullness
- Changes in how quickly meals feel satisfying
Others find the transition feels very smooth, especially when guided carefully. There’s no “right” or “wrong” response — just what’s right for you.
For guidance on what to eat during the early weeks of Mounjaro treatment, our free Mounjaro meal plan offers practical UK-friendly food ideas.
Managing Side Effects During the Switch
As with starting any new medication, mild side effects can occur during the transition. Both Wegovy and Mounjaro share a broadly similar, gastrointestinal-dominant profile — nausea is the most commonly reported effect, alongside diarrhoea, constipation, and sometimes vomiting, most often during the early titration weeks. These are usually mild to moderate and ease as the body adjusts; only a small proportion of patients stop because of side effects.
Helpful strategies often include:
- Keeping meals small and simple at first
- Staying well hydrated
- Prioritising protein
- Avoiding very rich foods in the early weeks
If side effects appear, your prescriber may suggest staying on the same dose for longer before increasing. For more detail on what to expect, see our comprehensive guide to Mounjaro side effects and how to manage them.
Most side effects are temporary
The majority of side effects experienced during a medication switch are mild to moderate and settle within the first few weeks as your body adjusts. Starting on a low dose and increasing gradually is the most effective way to minimise discomfort.
When to seek urgent medical advice
Although uncommon, stop and seek medical attention if you experience severe, persistent abdominal pain that may spread to your back (a possible sign of pancreatitis); persistent vomiting that prevents you keeping fluids down; or yellowing of the skin or eyes with fever (a possible sign of gallbladder problems). Seek emergency care for signs of a severe allergic reaction.
Common Mistakes to Avoid When Switching
Most problems people run into when changing medicines come from a handful of avoidable missteps. Being aware of them helps the switch go smoothly.
- Self-directing the switch. Changing medicines, or the gap between them, without prescriber input risks overlapping two long-acting medicines and increasing side effects.
- Doubling up or overlapping doses. Finishing Wegovy and starting Mounjaro should follow a planned timeline, not run alongside each other.
- Expecting instant appetite suppression. The 2.5mg starter dose is an adjustment phase; the stronger effects build at higher doses.
- Dropping diet and activity. The medicine supports lifestyle change rather than replacing it — results come from the two working together.
- Not reporting side effects. Telling your prescriber early means they can slow the titration or adjust support, rather than you struggling on alone.
After the Switch: Follow-Up and Monitoring
Switching is not a one-off event that ends once you’ve had your first Mounjaro injection — the weeks that follow are where pharmacist-led care earns its place. Ongoing review keeps the transition safe and gives you a point of contact when you need it.
In practice, follow-up usually covers:
- Tolerability and side effects — how you’re coping, and whether the titration pace needs adjusting.
- Progress — how your appetite and weight are responding as the dose builds.
- Ongoing suitability — confirming Mounjaro remains the right choice as things change.
- Dose decisions — whether to hold, increase, or settle at your current dose.
Between reviews, you don’t have to wait if something feels wrong — reach out to your pharmacist for advice. That accessible, named clinical support is a core part of how Slinic manages switches safely.
Wegovy and Mounjaro Pricing at Slinic
One factor worth considering when thinking about switching is the cost difference between the two medications. At Slinic, pricing is transparent at every dose, with no hidden consultation fees or subscription charges.
Mounjaro monthly pricing
| Dose | Monthly Price |
|---|---|
| 2.5mg (starter dose) | £139.00 |
| 5mg | £165.00 |
| 7.5mg | £225.00 |
| 10mg | £255.00 |
| 12.5mg | £275.00 |
| 15mg (maximum dose) | £285.00 |
Wegovy monthly pricing
| Dose | Monthly Price |
|---|---|
| 0.25mg (starter dose) | £99.99 |
| 0.5mg | £114.99 |
| 1mg | £149.99 |
| 1.7mg | £174.99 |
| 2.4mg (maximum dose) | £209.99 |
Both prices include the medication, pharmacist consultation, and delivery. For a full breakdown of what’s included at each dose, see our complete Mounjaro cost breakdown.
Cost Considerations When Switching
Because you restart Mounjaro at the 2.5mg starter dose, your first month or two after switching begins at the lower end of the Mounjaro price ladder (£139), then rises as the dose increases. It’s worth planning around the dose you expect to settle at rather than the starter price alone.
Looked at across a full year, Mounjaro typically costs in the region of £3,000 to £3,420 depending on the maintenance dose reached, while a first year of Wegovy works out at around £2,219.88. Mounjaro is the higher-priced of the two, but for some people its stronger average results represent better value measured against weight lost. The right balance of cost and effectiveness is individual.
Budget around what you can sustain
Weight management is usually a long-term commitment, so the most useful question is which treatment you can realistically afford and maintain. A medicine you keep up tends to deliver more than a cheaper one you stop early.
Preparing for Your Consultation
A switch goes more smoothly when your prescriber has the full picture. Before your consultation, it helps to have the following ready:
- Your current Wegovy dose and how long you have been on it
- How well you have tolerated treatment, and any side effects
- How much weight you have lost so far, and your goals
- Any other medicines or supplements you take
- Relevant medical history, including any conditions listed in the suitability section above
Having these to hand means the prescriber can plan the timing and dosing of your switch accurately and safely from the start.
Why Medical Guidance Is Essential
Switching between prescription weight loss injections should always involve a clinical review. This ensures:
- The switch is appropriate for your health
- Timing is planned safely
- Doses are adjusted at a comfortable pace
- You feel supported throughout the change
At Slinic, switching treatments is approached thoughtfully, with a focus on safety, reassurance, and clear communication.
Shadeia Younis
Superintendent Pharmacist, Slinic (GPhC 2052119)
Every Mounjaro and Wegovy prescription dispensed by Slinic is clinically verified and overseen by Shadeia Younis, our superintendent pharmacist. That means before your medication leaves our pharmacy it has been checked by a qualified, registered professional who is accountable for its safety.
This level of oversight is not standard across all online providers. Pharmacist-led dispensing means a real clinical expert reviews your treatment at every stage, not an automated system — which matters especially when switching between medications.
Frequently Asked Questions
Yes, many patients can switch from Wegovy to Mounjaro safely, provided it’s done with the support of a qualified prescriber. A structured, medically guided transition helps ensure comfort, safety, and the best chance of success.
In many cases, a short gap or carefully timed transition is recommended. The exact timing depends on your current Wegovy dose, how well you’ve tolerated treatment, any side effects, and your overall health profile. A prescriber will decide the safest timing.
Even if you’ve previously been on a higher dose of Wegovy, most people start Mounjaro on the lowest dose (2.5mg). This starter dose allows your body to adjust to the new medication and helps reduce the risk of side effects. Dose increases are then made gradually, based on how you respond.
Wegovy contains semaglutide, targeting one appetite-regulating hormone (GLP-1). Mounjaro contains tirzepatide, which works on two pathways (GLP-1 and GIP), influencing appetite and fullness in a broader way. People can experience each medication differently, which is why a personalised approach matters.
On average, tirzepatide produced greater weight loss than semaglutide in the head-to-head SURMOUNT-5 trial (20.2% vs 13.7% over 72 weeks). However, these are averages and individual responses vary considerably. Some people respond very well to one medication and less so to the other, which is why the choice is made with a prescriber rather than on trial figures alone.
Restarting Mounjaro at the 2.5mg starter dose does not undo the weight you have already lost. The starter dose simply lets your body adjust to the new medication; appetite effects typically build again as the dose increases over the following weeks. A prescriber will plan the transition to keep it as smooth as possible.
The 2.5mg starter dose is an adjustment phase, so appetite effects may feel milder at first. They typically build as the dose increases over the following weeks. Most people judge progress over months rather than days, alongside diet and activity changes. See our guide on how long Mounjaro takes to work.
Both medicines are designed to work alongside a balanced, reduced-calorie diet and regular activity rather than replace them. You don’t need a drastic or extreme diet; sensible, sustainable habits such as adequate protein, good hydration, and balanced meals support the best results. Our free Mounjaro meal plan offers practical ideas.
Some people notice appetite changes that feel slightly different, a renewed sense of fullness, and changes in how quickly meals feel satisfying. Others find the transition feels very smooth, especially when guided carefully.
Yes. If Mounjaro does not suit you, a prescriber can review switching back to Wegovy or discuss other options. As with any switch, it should be planned and supervised rather than done abruptly, to manage timing and side effects safely. Our guide on swapping from Mounjaro to Wegovy covers the reverse direction.
It depends on your circumstances. Switching is often considered once someone has given a medicine a fair trial or reached a maintenance dose, but the decision is individual. A prescriber will weigh up how long you’ve been on Wegovy, how you’ve responded, and your reasons for wanting to change.
At Slinic, Mounjaro is priced from £139 per month at the 2.5mg starter dose, rising to £285 at the 15mg maximum dose. Wegovy is priced from £99.99 at the 0.25mg starter dose to £209.99 at the 2.4mg maximum dose. Both prices include the medication, pharmacist consultation, and delivery, with no hidden fees.
Both medicines share a broadly similar, gastrointestinal-dominant side effect profile, with nausea the most common effect. Side effects tend to be mild to moderate, peak during dose increases, and ease as the body adjusts. Starting Mounjaro at the low 2.5mg dose and titrating slowly is the main way the risk is kept manageable.
Contact your prescriber or pharmacist for advice rather than guessing or doubling up doses. They can confirm the safest way to get back on track, taking into account when you had your last Wegovy injection.
Yes. Slinic is a GPhC-registered pharmacy (1033729) with Superintendent Pharmacist Shadeia Younis (GPhC: 2052119). All prescribers are GMC-registered doctors and GPhC-registered pharmacists only. Both registrations are publicly verifiable on the GPhC register.
Related Guides and Pages
Mounjaro & Wegovy Treatment Guides
These articles answer the questions most patients have when comparing and switching between weight loss injections.
- Weight loss injections in the UK: complete clinician-led guide – Our pillar guide to how GLP-1 treatments work and who they suit.
- Swapping from Mounjaro to Wegovy – The opposite direction: when and how to switch from Mounjaro to Wegovy safely.
- Mounjaro dosing schedule explained – How the titration works from 2.5mg through to 15mg.
- How long does Mounjaro take to work? – Realistic timelines for weight loss results month by month.
- Mounjaro results week by week – What weight loss progress typically looks like over time.
- Mounjaro side effects: what UK patients should expect – Why side effects happen, when they peak, and what helps.
- How to store Mounjaro: UK guide – Keeping your pen stored safely and correctly.
- Free Mounjaro meal plan UK – A practical eating plan for early treatment.
- The complete Mounjaro cost breakdown 2026 – Monthly pricing at every dose, what’s included, and how to compare providers.
Key Slinic Pages
- Weight loss treatment & consultation – Start your assessment for Mounjaro or Wegovy. Takes around three minutes.
- About Slinic – Who we are, our GPhC registration, and our pharmacist-led model.
Medical References and Guidance
Clinical guidance in this article is based on the Mounjaro (tirzepatide) and Wegovy (semaglutide) Summary of Product Characteristics (SPC) as approved by the MHRA for use in the UK. Comparative trial data is from the SURMOUNT-5 head-to-head trial (NEJM 2025), with supporting data from SURMOUNT-1 (NEJM 2022) and STEP-1 (NEJM 2021); the regain after stopping treatment is from STEP-4 (JAMA 2021). NICE Technology Appraisal TA1026 covers tirzepatide for weight management in adults (published December 2024). All medical facts in Slinic content are verified against MHRA, NICE, NHS, and BNF sources.
Thinking About Making the Switch?
Switching from Wegovy to Mounjaro isn’t about starting over — it’s about finding the right fit for your body and your goals. When done properly, with medical guidance and realistic expectations, many people find the transition straightforward and manageable. Complete our online consultation and a prescriber will review your information within 24 hours.
Start Your Confidential ConsultationMedical Disclaimer
This article provides educational guidance about switching between weight loss medications and is not a substitute for professional medical advice. Both Mounjaro and Wegovy are prescription-only medicines and should only be used together with a reduced-calorie diet and increased physical activity under appropriate clinical supervision. Always consult qualified healthcare providers before starting or switching weight loss medication. Individual results vary.
Related Blog Posts From Slinic
Mounjaro and Wegovy Together: Clinical Safety and Switching Protocols – clinical safety and switching protocols for Mounjaro and Wegovy.
Ozempic vs Mounjaro vs Wegovy UK: The Specialist Guide – a specialist guide to the key differences between Ozempic, Mounjaro and Wegovy in the UK.
How to Get a Legal Wegovy Prescription Online: A UK Patient Guide – a UK patient guide to getting a legal Wegovy prescription online.
